A Pilot Study of the Use of Mycophenolate Mofetil as a Component of Therapy for Multidrug-Resistant HIV-1 Infection

This publication has 29 references indexed in Scilit:

• Sustained CD4⁺T Cell Response after Virologic Failure of Protease Inhibitor–Based Regimens in Patients with Human Immunodeficiency Virus Infection
  The Journal of Infectious Diseases, 2000
• CD69 and Regulatiof the Immune Function
  Immunopharmacology and Immunotoxicology, 1999
• Long-term suppression of HIV-1 by hydroxyurea and didanosine
  Published by American Medical Association (AMA) ,1997
• AIDS and the death receptors
  British Medical Bulletin, 1997
• Pharmacokinetics of Oral Mycophenolate Mofetil in Volunteer Subjects with Varying Degrees of Hepatic Oxidative Impairment
  The Journal of Clinical Pharmacology, 1996
• Pharmacokinetics and Bioavailability of Mycophenolate Mofetil in Healthy Subjects after Single‐Dose Oral and Intravenous Administration
  The Journal of Clinical Pharmacology, 1996
• Mycophenolate Mofetil
  Drugs, 1996
• Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl.
  The Journal of Experimental Medicine, 1995
• The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells
  Immunology Today, 1994
• Mechanisms of Action of Mycophenolic Acid
  Annals of the New York Academy of Sciences, 1993